Citation

Roller L, Gowan J. Australian Journal of Pharmacy 2016; 97(1151): 66-74.

Copyright

(Copyright © 2016)

DOI

unavailable

PMID

unavailable

Abstract

With the listing of new hepatitis C drugs on the PBS from 1 March this year, pharmacists will play an important role in providing appropriate patient counselling and support.

Language: en

Keywords

human; suicide; quality of life; exercise; insomnia; suicidal ideation; depression; drug use; alcohol consumption; fatigue; pancreatitis; high risk population; neutropenia; vertigo; gastrointestinal symptom; dehydration; sexual intercourse; drug dependence; sepsis; hepatitis C; eosinophilia; patient counseling; alopecia; asthenia; heart arrhythmia; hepatitis; anemia; arthralgia; flu like syndrome; Hepatitis C virus; myalgia; pruritus; ribavirin; blood transfusion; dyspnea; coughing; liver cirrhosis; angioneurotic edema; bradycardia; malaise; pneumonia; bone marrow suppression; drug fever; dizziness; drug eruption; pancytopenia; urticaria; rigor; Hepatitis A virus; Hepatitis B virus; kidney graft rejection; drug bioavailability; Article; dry skin; chill; drug induced headache; injection site reaction; decreased appetite; rhinopharyngitis; Hepatitis delta virus; lung infiltrate; facial nerve paralysis; peginterferon alpha; pure red cell anemia; reinfection; liver graft rejection; retina detachment; boceprevir; condom use; bronchoconstriction; Hepatitis C virus genotype 2; Hepatitis C virus genotype 3; sofosbuvir; asunaprevir; daclatasvir; Hepatitis C virus genotype 1; Hepatitis C virus genotype 4; Hepatitis C virus genotype 5; Hepatitis C virus genotype 6; Hepatitis E virus; ledipasvir plus sofosbuvir; peginterferon alpha2a plus ribavirin; viral clearance